B-cell depletion therapies, in which B cells of the immune system that may drive disease activity in multiple sclerosis (MS) ...

B-cell depletion therapies in multiple sclerosis (MS) work in part by mobilizing protective B cells from the gut.

Several children who had aggressive recurrent brain tumors remained disease-free years after this treatment, according to an ...

The government has decided to directly support clinical research on advanced regenerative medicine utilizing stem cells or immune cells and to lower the treatment threshold for technologies where ...

New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach ...

Prostate cancer is often resistant to immunotherapy, which harnesses a person's immune system to recognize and destroy tumors ...

An experimental immunotherapy has beaten aggressive brain tumours in a handful of children, and a personalised version is now ...

A novel immunotherapy could lead to a brain cancer breakthrough after showing promising results against glioblastoma, the ...

CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...

What Is It, and Why Does It Matter? Tecelra (afamitresgene autoleucel) is a prescription-based personalized T-cell immune therapy for treating synovial sarcoma, a rare type of cancer affecting soft ...

Funding will support completion of IND-enabling activities and planned year-end IND submission for TAVST01, Tikva's lead off-the-shelf CAR-T candidate targeting B7-H3-positive solid tumors ...

Memory B cells and tertiary lymphoid structures predicted BCG response and longer recurrence free survival in non muscle ...